SHR-2001
/ Jiangsu Hengrui Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
June 26, 2025
A Phase I Study of SHR -2001 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=72 | Completed | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Recruiting ➔ Completed | N=49 ➔ 72 | Trial completion date: Dec 2023 ➔ Nov 2024 | Trial primary completion date: Dec 2023 ➔ Nov 2024
Enrollment change • Trial completion • Trial completion date • Trial primary completion date
August 14, 2023
A Phase I Study of SHR -2001 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=49 | Recruiting | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Not yet recruiting ➔ Recruiting
Enrollment open
July 12, 2023
A Phase I Study of SHR -2001 in Healthy Subjects
(clinicaltrials.gov)
- P1 | N=52 | Not yet recruiting | Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd
New P1 trial
1 to 3
Of
3
Go to page
1